Clinical Laserthermia (Sweden) Today
| CLS-B Stock | SEK 3.40 0.04 1.19% |
PerformanceVery Weak
| Odds Of DistressBelow Average
|
Clinical Laserthermia is selling for under 3.40 as of the 27th of February 2025; that is 1.19% up since the beginning of the trading day. The stock's lowest day price was 3.26. Clinical Laserthermia has about a 43 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 28th of January 2025 and ending today, the 27th of February 2025. Click here to learn more.
Clinical Laserthermia Systems AB develops and markets therapies, systems, and single-use instruments for thermal treatment of solid cancer tumors in Sweden. Clinical Laserthermia Systems AB has a collaboration agreement with Image Guided Therapy SA to develop and commercialize a software product for MR-generated temperature monitoring and a collaborative license and co-development agreement with MRI Interventions, Inc. The company has 134.52 M outstanding shares. More on Clinical Laserthermia Systems
Moving against Clinical Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Clinical Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Clinical Laserthermia's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Clinical Laserthermia or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Medical Devices, Healthcare (View all Sectors) |
Clinical Laserthermia Systems (CLS-B) is traded on Stockholm Exchange in Sweden and employs 12 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 104.76 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Clinical Laserthermia's market, we take the total number of its shares issued and multiply it by Clinical Laserthermia's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Clinical Laserthermia operates under Healthcare sector and is part of Medical Devices industry. The entity has 134.52 M outstanding shares.
Clinical Laserthermia Systems has accumulated about 13.5 M in cash with (66.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.39.
Check Clinical Laserthermia Probability Of Bankruptcy
Ownership AllocationClinical Laserthermia holds a total of 134.52 Million outstanding shares. Clinical Laserthermia Systems shows 9.7 percent of its outstanding shares held by insiders and 2.27 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Clinical Ownership Details
Clinical Laserthermia Risk Profiles
Although Clinical Laserthermia's alpha and beta are two of the key measurements used to evaluate Clinical Laserthermia's performance over the market, the standard measures of volatility play an important role as well.
Clinical Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Clinical Laserthermia without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Price Transformation Now
Price TransformationUse Price Transformation models to analyze the depth of different equity instruments across global markets |
| All Next | Launch Module |
Clinical Laserthermia Corporate Management
Elected by the shareholders, the Clinical Laserthermia's board of directors comprises two types of representatives: Clinical Laserthermia inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Clinical. The board's role is to monitor Clinical Laserthermia's management team and ensure that shareholders' interests are well served. Clinical Laserthermia's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Clinical Laserthermia's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Rolf Bornschein | Chief Officer | Profile | |
| Mats Ekelund | Chief Officer | Profile | |
| LarsErik Eriksson | CoFounder Director | Profile | |
| Stephan MSc | Head Devel | Profile | |
| Karin Peterson | Chief Officer | Profile | |
| Marie MSc | Quality Mang | Profile | |
| Dan Mogren | Chief Officer | Profile |
Additional Tools for Clinical Stock Analysis
When running Clinical Laserthermia's price analysis, check to measure Clinical Laserthermia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clinical Laserthermia is operating at the current time. Most of Clinical Laserthermia's value examination focuses on studying past and present price action to predict the probability of Clinical Laserthermia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clinical Laserthermia's price. Additionally, you may evaluate how the addition of Clinical Laserthermia to your portfolios can decrease your overall portfolio volatility.